391 related articles for article (PubMed ID: 34745215)
1. Identifying New COVID-19 Receptor Neuropilin-1 in Severe Alzheimer's Disease Patients Group Brain Using Genome-Wide Association Study Approach.
Lim KH; Yang S; Kim SH; Joo JY
Front Genet; 2021; 12():741175. PubMed ID: 34745215
[TBL] [Abstract][Full Text] [Related]
2.
Hu S; Hu Z; Qin J; Lin C; Jiang X
Aging (Albany NY); 2021 Jun; 13(12):15770-15784. PubMed ID: 34168096
[TBL] [Abstract][Full Text] [Related]
3. Ubiquity of the SARS-CoV-2 receptor ACE2 and upregulation in limbic regions of Alzheimer's disease brain.
Zhao Y; Li W; Lukiw W
Folia Neuropathol; 2021; 59(3):232-238. PubMed ID: 34628788
[TBL] [Abstract][Full Text] [Related]
4. Tumor Necrosis Factor and Interleukin-1β Upregulate NRP2 Expression and Promote SARS-CoV-2 Proliferation.
Ishitoku M; Mokuda S; Araki K; Watanabe H; Kohno H; Sugimoto T; Yoshida Y; Sakaguchi T; Masumoto J; Hirata S; Sugiyama E
Viruses; 2023 Jul; 15(7):. PubMed ID: 37515185
[TBL] [Abstract][Full Text] [Related]
5. Neuropilin-1-Mediated SARS-CoV-2 Infection in Bone Marrow-Derived Macrophages Inhibits Osteoclast Differentiation.
Gao J; Mei H; Sun J; Li H; Huang Y; Tang Y; Duan L; Liu D; Pang Y; Wang Q; Gao Y; Song K; Zhao J; Zhang C; Liu J
Adv Biol (Weinh); 2022 May; 6(5):e2200007. PubMed ID: 35195371
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic targeting of the ACE2 and NRP1 viral receptors limits SARS-CoV-2 infectivity.
Saiz ML; DeDiego ML; López-García D; Corte-Iglesias V; Baragaño Raneros A; Astola I; Asensi V; López-Larrea C; Suarez-Alvarez B
Clin Epigenetics; 2021 Oct; 13(1):187. PubMed ID: 34635175
[TBL] [Abstract][Full Text] [Related]
7. Hydroxychloroquine treatment on SARS-CoV-2 receptor ACE2, TMPRSS2 and NRP1 expression in human primary pterygium and conjunctival cells.
Yao Y; Ma D; Xu Y; Yuan XL; Liang JJ; Chen SL; Jhanji V; Ng TK
Exp Eye Res; 2022 Jan; 214():108864. PubMed ID: 34826419
[TBL] [Abstract][Full Text] [Related]
8. Age-Related Differences in the Expression of Most Relevant Mediators of SARS-CoV-2 Infection in Human Respiratory and Gastrointestinal Tract.
Berni Canani R; Comegna M; Paparo L; Cernera G; Bruno C; Strisciuglio C; Zollo I; Gravina AG; Miele E; Cantone E; Gennarelli N; Nocerino R; Carucci L; Giglio V; Amato F; Castaldo G
Front Pediatr; 2021; 9():697390. PubMed ID: 34395341
[No Abstract] [Full Text] [Related]
9. Emerging Role of Neuropilin-1 and Angiotensin-Converting Enzyme-2 in Renal Carcinoma-Associated COVID-19 Pathogenesis.
Hossain MG; Akter S; Uddin MJ
Infect Dis Rep; 2021 Oct; 13(4):902-909. PubMed ID: 34698182
[TBL] [Abstract][Full Text] [Related]
10. Soluble Neuropilin-1 Response to Hypoglycemia in Type 2 Diabetes: Increased Risk or Protection in SARS-CoV-2 Infection?
Moin ASM; Al-Qaissi A; Sathyapalan T; Atkin SL; Butler AE
Front Endocrinol (Lausanne); 2021; 12():665134. PubMed ID: 34248841
[TBL] [Abstract][Full Text] [Related]
11. Discovery of natural products to block SARS-CoV-2 S-protein interaction with Neuropilin-1 receptor: A molecular dynamics simulation approach.
Alshawaf E; Hammad MM; Marafie SK; Ali H; Al-Mulla F; Abubaker J; Mohammad A
Microb Pathog; 2022 Sep; 170():105701. PubMed ID: 35963279
[TBL] [Abstract][Full Text] [Related]
12. Characterization of peptide binding to the SARS-CoV-2 host factor neuropilin.
Jobe A; Vijayan R
Heliyon; 2021 Oct; 7(10):e08251. PubMed ID: 34722943
[TBL] [Abstract][Full Text] [Related]
13. Neuropilin-1 assists SARS-CoV-2 infection by stimulating the separation of Spike protein S1 and S2.
Li ZL; Buck M
Biophys J; 2021 Jul; 120(14):2828-2837. PubMed ID: 34087218
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the SARS-CoV-2 co-receptor NRP1 expression profiles in healthy people and cancer patients: Implication for susceptibility to COVID-19 disease and potential therapeutic strategy.
Huang Y; Wang Y; Xu D; Xiao L; Qin W; Liu B; Yuan X
Front Genet; 2022; 13():995736. PubMed ID: 36338984
[TBL] [Abstract][Full Text] [Related]
15. A Comprehensive Analysis of NRP1 in Malignancies Provide Therapeutic Implication for Treating Cancer Patients Infected with SARS-CoV-2.
Chen S; Zhang L; Song Y; Xie K; Wang Y; Liang Y
Biochem Genet; 2023 Nov; ():. PubMed ID: 37938510
[TBL] [Abstract][Full Text] [Related]
16. Neuropilin 1: A Novel Entry Factor for SARS-CoV-2 Infection and a Potential Therapeutic Target.
Chekol Abebe E; Mengie Ayele T; Tilahun Muche Z; Asmamaw Dejenie T
Biologics; 2021; 15():143-152. PubMed ID: 33986591
[TBL] [Abstract][Full Text] [Related]
17. Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity.
Cantuti-Castelvetri L; Ojha R; Pedro LD; Djannatian M; Franz J; Kuivanen S; van der Meer F; Kallio K; Kaya T; Anastasina M; Smura T; Levanov L; Szirovicza L; Tobi A; Kallio-Kokko H; Österlund P; Joensuu M; Meunier FA; Butcher SJ; Winkler MS; Mollenhauer B; Helenius A; Gokce O; Teesalu T; Hepojoki J; Vapalahti O; Stadelmann C; Balistreri G; Simons M
Science; 2020 Nov; 370(6518):856-860. PubMed ID: 33082293
[TBL] [Abstract][Full Text] [Related]
18. Molecular basis of the new COVID-19 target neuropilin-1 in complex with SARS-CoV-2 S1 C-end rule peptide and small-molecule antagonists.
Klaewkla M; Charoenwongpaiboon T; Mahalapbutr P
J Mol Liq; 2021 Aug; 335():116537. PubMed ID: 34031621
[TBL] [Abstract][Full Text] [Related]
19. Virus-receptor interactions of SARS-CoV-2 spikereceptor-binding domain and human neuropilin-1 b1 domain.
Alnomasy SF
Saudi J Biol Sci; 2021 Jul; 28(7):3926-3928. PubMed ID: 33850424
[TBL] [Abstract][Full Text] [Related]
20. The Expression Levels of SARS-CoV-2 Infection-Mediating Molecules Promoted by Interferon-γ and Tumor Necrosis Factor-α Are Downregulated by Hydrogen Sulfide.
Zhao X; Cao Y; Zhao E; Li T; Cong T; Gao Y; Zhang J
Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
